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The catalytic pathway of class A ￿-lactamases involves
an acyl-enzyme intermediate where the substrate is es-
ter-linked to the Ser-70 residue. Glu-166 and Lys-73 have
been proposed as candidates for the role of general base
in the activation of the serine OH group. The replace-
ment of Glu-166 by an asparagine in the TEM-1 and by a
histidine in the Streptomyces albus G ￿-lactamases
yielded enzymes forming stable acyl-enzymes with
￿-lactam antibiotics. Although acylation of the modified
proteins by benzylpenicillin remained relatively fast, it
was significantly impaired when compared to that ob-
served with the wild-type enzyme. Moreover, the E166N
substitution resulted in a spectacular modification of
the substrate profile much larger than that described
for other mutations of ￿-loop residues. Molecular mod-
eling studies indicate that the displacement of the cata-
lytic water molecule can be related to this observation.
These results confirm the crucial roles of Glu-166 and of
the “catalytic” water molecule in both the acylation and
the deacylation processes.
DD-peptidases and most ￿-lactamases, belong to the super-
family of active-site serine penicillin-recognizing enzymes (1).
The interaction between these proteins and ￿-lactams involves
the formation of an acyl-enzyme (E-S*) intermediate where the
antibiotic is covalently bound to the active-site serine residue,
E￿ SO
k1
k￿1
ESO
k2
ES*O
k3
E￿ P (Eq. 1)
In contrast to DD-peptidases, ￿-lactamases efficiently catalyze
the deacylation step (high k3 value) which regenerates the
active enzyme and releases a biologically inactive product (P).
Serine ￿-lactamases are divided into three classes A, C, and D
on the basis of their primary structures. Tertiary structures of
various enzymes belonging to classes A and C have been solved
by x-ray crystallography underlining similarities in the folds of
all these proteins (2–6). Moreover, several conserved residues
were identified, some of which appear to be essential for
catalysis (7).
The mechanism by which serine ￿-lactamases hydrolyze pen-
icillins and cephalosporins has received a lot of attention and,
for the class A enzymes the identity of the residue involved in
the activation of the active serine (Ser-70 in the ABL number-
ing system (8)) has been subject of controversy. Both Lys-73 (9)
and Glu-166 (10) have been proposed as potential candidates
for this essential role. By contrast, the function of Glu-166 in
activating the hydrolytic water molecule during the deacyla-
tion step is unanimously recognized. According to Adachi et al.
(11) and Strynadka et al. (9), accumulation of an acyl-enzyme
during the interaction between the TEM-1 Glu-166 3 Asn
mutant (E166N) and benzylpenicillin suggested that the mu-
tation affected only the deacylation step in a severe manner. In
contrast, kinetic studies of the Glu-166 3 Ala mutant of the
Bacillus licheniformis ￿-lactamase (12) and of the Glu-166 3
Asp mutant of the Bacillus cereus I ￿-lactamase (13) showed
that accumulation of the acyl-enzyme could result from simul-
taneous but different decreases of the kinetic parameters char-
acterizing the acylation and deacylation steps.
The present paper reports the analysis of the kinetic prop-
erties of the TEM-1 E166N mutant. Methods were developed to
monitor the rapid formation of the acyl-enzyme. One of the
most striking results was a sharp modification of the substrate
profile of the enzyme. To explain these results, the interactions
between different ￿-lactams and the E166N mutant were an-
alyzed by molecular modeling. These confirmed the role of the
catalytic water molecule in the mechanism and underlined the
importance of the ￿-loop residues in the specificity profile.
Similar kinetic data were obtained with the E166H mutant of
the Streptomyces albus G class A ￿-lactamase.
EXPERIMENTAL PROCEDURES
Strains and Plasmids
Escherichia coli TG1 strain (￿(lac-pro), Sup E, thi, hsdD5/F￿traD36,
proA￿ B￿, lacIq, lacZ￿M15) was used for routine transformation, DNA
preparation and production of the TEM-1 ￿-lactamase and as a host
strain for M13 phage growth. The Streptomyces lividans TK24 strain
(14) was utilized for the production of the Streptomyces albus G
￿-lactamase.
Plasmid pAD25 (15) encodes both the tetracycline resistance and an
isopropyl ￿-D-thiogalactopyranoside-inducible TEM-1 ￿-lactamase. It
was used both for the mutagenesis procedure and the expression of the
WT1 and mutant enzymes.
The gene encoding the S. albus G ￿-lactamase was cloned into the
M13tg131 phage for mutagenesis. The mutant gene was entirely se-
quenced, recloned into the pIJ702￿ Streptomyces plasmid (a gift from
Dr. J. Altenbu¨chner, Universita¨t-Regensburg, Germany), and ex-
pressed in S. lividans.
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Nucleic Acid Techniques
Sequencing was performed by the method of Sanger et al. (16) using
the Sequenase sequencing kit (U. S. Biochemical Corp.). T4 DNA ligase
and kinase were purchased from Boehringer Mannheim GmbH. Oligo-
nucleotides were purchased from Eurogentec (Lie`ge, Belgium). Specific
Streptomyces DNA manipulations, such as protoplast preparation,
transformation, and plasmid extraction, were based on Hopwood et al.
(17).
Mutagenesis
The E166N TEM-1 ￿-lactamase mutant was obtained by inverse
polymerase chain reaction mutagenesis (18) with the following oligonu-
cleotides: 5￿-AAGGCGAGTTACATGATCCCC-3￿; 5￿-GTAAGTCGAG-
GCCCAAGGTTGCTAG-3￿. The latter carried the two mismatched
bases designed to mutate the GAA (Glu) codon into AAC (Asn).
Amplification was performed with the Vent DNA polymerase (Bio-
labs) in the buffer supplied by the manufacturer to which MgSO4 was
added to a final concentration of 4 mM; 30 cycles (60 s at 94 °C, 60 s at
56 °C, 270 s at 72 °C) were performed on the reaction mixture. The
polymerase chain reaction product was subsequently treated as de-
scribed by Imai et al. (19) and used to transform E. coli TG1.
For the E166H mutant of the S. albus G ￿-lactamase, mutagenesis
was performed as described by Eckstein et al. (20). The oligonucleotide
used to replace the GAC (Glu) codon by CAC (His) was
5￿-CTCGACCGCTGGCACCCGGAGCTGAAC-3￿.
Chemicals
Benzylpenicillin was from Rhoˆne Poulenc (Paris, France), cefuroxime
and ceftazidime were from Glaxo Group Research (Greenford, Mid-
dlesex, United Kingdom), cefotaxime from Hoechst-Roussel (Romain-
ville, France). Imipenem, moxalactam, temocillin, and cefoxitin from
Merck, Sharp and Dohme Research Laboratories (Rahway, NJ). Ceph-
alosporin C and cephaloridine from Eli Lilly and Co. (Indianapolis, IN).
All these compounds were kindly given by the respective companies.
[14C]Benzylpenicillin (54 mCi/mmol) was purchased from Amersham
International.
Isopropyl ￿-D-thiogalactopyranoside and tetracycline were pur-
chased from Sigma. Fluoresceyl-6-aminopenicillanic acid was prepared
as described by Lakaye et al. (21).
Expression and Purification of Mutant ￿-Lactamases
The E166H mutant of the S. albus G ￿-lactamase was isolated from
3 liters of culture supernatant and purified as described by Brannigan
et al. (22) with an additional chromatographic step on a Superdex 75 HR
10/30 column in 25 mM sodium phosphate buffer, pH 7.
For the production of the E166N TEM-1 mutant, E. coli TG1 was
grown at 30 °C in 15 liters of M9 minimal medium supplemented with
50 ￿g/ml tetracycline. When the A550 value reached 0.6, 0.1 mM isopro-
pyl ￿-D-thiogalactopyranoside was added and the culture was further
incubated for 3 h. Cells were collected, suspended in a 30 mM Tris-HCl
buffer, pH 7, containing 27% sucrose (w/v) and lysed by lysozyme (1
mg/ml final) as described by Dubus et al. (15). Cell debris were dis-
carded by centrifugation and the supernatant dialyzed against 10 mM
Tris-HCl, pH 7.5. The enzyme was purified as described by Vanhove et
al. (23). The fractions containing the enzyme were identified by sub-
mitting samples of fluoresceyl-6-aminopenicillanic acid-labeled enzyme
to electrophoresis on a 15% polyacrylamide gel in the presence of SDS
(24).
The purity of the different enzyme preparations was verified by
Coomassie Blue staining of SDS-polyacrylamide electrophoresis gels.
The TEM-1 mutant was titrated with [14C]benzylpenicillin and found to
be more than 95% pure. The E166H mutant of S. albus G was only 50%
pure and remained contaminated by a single, low molecular mass
protein which did not interfere with the kinetic measurements.
Determination of the Kinetic Parameters
Due to the very low k3 values observed with these two mutants the
determination of their kinetic parameters rested on methods similar to
those used for penicillin-binding proteins rather than for regular ￿-lac-
tamases. Unless otherwise mentioned, all the kinetic assays were per-
formed at 30 °C in 50 mM sodium phosphate buffer, pH 7.
Determination of k2/K Values
Pseudo-first order reactions are only obtained when the ￿-lactam
concentration is at least five times greater than that of enzyme. Due to
the high k2/K values, these conditions where only fulfilled when the
experiments were performed in a stopped-flow apparatus. The ￿-lactam
concentration was also decreased close to that of enzyme and analysis
performed according to the general second order equation. Finally after
the direct determination of the k2/K values for cefoxitin and cephalos-
porin C, those for the other compounds were determined by a competi-
tion method.
Direct Determination with Manual Mixing (Method A)
The enzyme solution was added with cefoxitin, cephalosporin C,
cefotaxime, moxalactam, or ceftazidime. The total volume was 0.5 ml
and the final enzyme concentration 16 ￿M. The antibiotic concentration
was always slightly higher than that of the enzyme. Decrease of the
A260 value resulting from the opening of the ￿-lactam ring was moni-
tored with the help of an Uvikon spectrophotometer connected to a
COPAM PC88C microcomputer. The data were fitted to Equation 2
using the Enzfitter program (Biosoft, Cambridge, United Kingdom (25))
yielding the value of the second-order rate constant k, i.e. k2/K￿, where
K￿ ￿ (k￿1 ￿ k2)/k￿1. Under conditions of similar initial enzyme and
substrate concentration, the general Equation 2 prevails.
ln￿￿E0￿ x￿/￿S0￿ x￿￿￿ ln￿E0/S0￿￿ ￿E0￿ S0￿k ￿ t (Eq. 2)
where S0 and E0 are the initial concentrations of substrate and enzyme
and x the concentration of E (or S) transformed at time t.
Under our experimental conditions (S0 ￿ E0) concentrations could be
replaced by absorbance values as in Equation 3, leading to Equation 4,
E0￿ ￿A0￿ A￿￿/￿￿ ; S0￿ ￿A0￿ A￿￿ ￿ ￿S0/E0￿/￿￿ and x￿ ￿A0￿ At￿/￿￿
(Eq. 3)
where A0, At, A￿, are the absorbance values at times 0, t, and at the end
of the reaction and ￿￿ is the variation of the substrate molar extinction
coefficient upon hydrolysis.
￿At￿ A￿￿/￿￿S0/E0￿￿A0￿ A￿￿￿ A0￿ At￿]￿ ￿1/￿S0/E0￿￿exp￿￿￿A0￿ A￿￿
￿ ￿1￿ S0/E0￿/￿￿￿kt￿ (Eq. 4)
Stopped-flow Experiments (Method B)
The enzyme (16 ￿M) was mixed with increasing concentrations of
cefoxitin with the help of a Biologic Stopped-flow apparatus (Grenoble,
France). The S0/E0 ratio ranged from 1.2 to 25. For data analysis,
Equation 2 was adapted to the stopped-flow recording conditions. Al-
ternatively, for the highest S0/E0 ratios the pseudo-first order approx-
imation was used, yielding identical results.
Competition Method (Method C)
The enzyme (0.9 ￿M) was added with a mixture of [14C]benzylpeni-
cillin (B) and another antibiotic (I) at concentrations ranging from 2.5￿
10￿6 to 1.0 ￿ 10￿4 M. After 5 min, the reaction was stopped and the
protein precipitated, isolated, and the radioactivity determined as de-
scribed by Martin and Waley (26). Since both antibiotic concentrations
were larger than that of the enzyme and the incubation time was much
shorter than the half-life of both acyl-enzymes (see below), the respec-
tive quantities of labeled (E-B* formed with [14C]benzylpenicillin) and
unlabeled (E-I* formed with the other antibiotic) acyl-enzymes were
given by Equation 5 as shown by Fre`re et al. (27),
￿EI*￿/￿EB*￿￿ ￿k2/K￿I￿I￿/￿k2/K￿B￿B￿ (Eq. 5)
The value of [EI*] was estimated as [EB*]0 ￿ [EB*], where [EB*]0 was
the quantity of acyl-enzyme formed with [14C]benzylpenicillin in the
absence of competing substrate.
Direct Binding of a Labeled Antibiotic (Method D)
With the E166H mutant of the S. albus G enzyme the second-order
rate constant for acylation (k2/K￿) was obtained by monitoring acyl-
enzyme formation as a function of time (method D). The enzyme was
incubated with an excess of [14C]benzylpenicillin (S0 ￿￿ E0) and after
increasing periods of time, the reaction was stopped by addition of 1%
SDS. The labeled acyl-enzyme was isolated by SDS-polyacrylamide gel
electrophoresis and quantified by fluorography (24).
Determination of k3
Labeled Antibiotic—The protein (1.6 ￿M) was reacted with an excess
of [14C]benzylpenicillin (10￿4 M) and the excess of free antibiotic elim-
inated by addition of 600 ng of the wild-type enzyme. The mixture was
incubated at 30 °C and after increasing periods of time, the residual
acyl-enzyme quantified after precipitation as above (26).
Unlabeled Antibiotics—After formation of the acyl-enzyme in 50 mM
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cacodylate buffer, pH 7, at 30 °C, the excess of unlabeled antibiotic was
hydrolyzed by addition of the Zn-￿-lactamase of B. cereus (1 ￿M) and 100
￿M ZnCl2. The acyl-enzyme was then left to decay during different time
periods. 1 mM EDTA was added to inactivate the Zn-￿-lactamase and
the regenerated active-serine enzyme was quantified by saturation
with [14C]benzylpenicillin and precipitation as above. With both labeled
and unlabeled antibiotics, the degradation of the acyl-enzyme obeyed
simple first-order kinetics (28).
pH Dependence of the Enzyme Activity
The following pH range was explored: acetic acid/sodium acetate, pH
4–5.5, sodium phosphate, pH 6–8, Tris-HCl, pH 8.5–9. All the buffers
were 50 mM. These experiments were performed with the help of
method A for the E166N mutant and method D for the E166H mutant.
For the TEM-1 wild-type enzyme, the kcat/Km value was obtained by
determining initial rates (v0) at substrate concentrations well below the
Km value.
The data obtained for the wild-type TEM-1 and the E166N mutant
were fitted to Equation 6 by means of the Enzfitter program,
kobs￿ klim/￿1￿ ￿H￿￿/K1￿K2/￿H￿￿￿￿ klim2/￿1￿K2/￿H￿￿￿ (Eq. 6)
Alternatively, fitting of the same data was performed with klim2 ￿ 0.
The pH dependence of k3 characterizing the degradation rate of the
E166N-[14C]benzylpenicillin adduct was investigated in the same
buffers.
Thermal Denaturation Curves
Temperature-induced unfolding was monitored by recording the in-
trinsic fluorescence of the TEM-1 E166N as described by Vanhove et al.
(29).
The cuvette containing the sample (1.4 ml) was heated at a rate of
0.9 °C/min using a thermostatically regulated circulating water bath.
The enzyme unfolded reversibly in a simple co-operative fashion. Un-
folding curves were analyzed according to Equation 7 by means of the
nonlinear regression data analysis Enzfitter program,
Fmes￿ ￿￿N￿ yT￿￿ ￿U￿ zT￿exp a￿/￿1￿ exp a￿ (Eq. 7)
with a ￿ ￿Hm [(T/Tm) ￿ 1]/RT, where Tm is the midpoint at the
transition and ￿Hm is the enthalpy of unfolding at Tm. The (N￿ yT) and
(U￿ zT) terms were necessary to account for the linear decreases of the
intrinsic fluorescences of the native and denatured states of the protein
(N and U, respectively) upon increasing temperature.
Proteolysis Experiments
A mixture containing 0.2 mg of enzyme and 0.02 mg of trypsin was
incubated in 100 mM Tris-HCl, pH 7.5, at 40 °C. Aliquots were removed
and trypsin was inactivated by addition of 40 mg/ml soybean trypsin
inhibitor (Sigma). Quantification of the mutant residual activity was
performed by titration with [14C]benzylpenicillin.
Optimized Structures of the Substrates
The structures of the ￿-lactam molecules were optimized by the AM1
semi-empirical method (Dewar et al. (30)). CNDO charges were adopted
for these ligands. The bond lengths, bond angles, and ring dihedral
angles of the antibiotics were constrained to the AM1 values.
Molecular Modeling
Models of the mutant enzymes were obtained from the x-ray struc-
tures of the wild-type proteins (5) and the local conformational space of
the mutated amino acid was searched by a minimum perturbation
approach (31).
The system was solvated by cubes of standard “Monte Carlo” water
molecules and the positions of these molecules after minimization were
compared to those in the crystal structures. The geometry of the protein
was optimized with the AMBER 4.1 set of programs (32) using a
distance-dependent dielectric constant.
The ￿-lactam molecules were docked in the modeled active sites with
the ￿-lactam amide oxygen atom oriented into the oxyanion-hole formed
by the main chain nitrogen atoms of Ser-70 and Ala-237. Hydrogen
bonds appeared to be formed between the C7 side chain amide group
and the N￿2 amide nitrogen atom of Asn-132 and the main chain oxygen
atom of Ala-237. The energy of the Michaelis complexes thus obtained
was minimized using AMBER (32).
RESULTS
Production and Purification—About 16 mg of the TEM-1
E166N mutant were obtained per liter of culture. The protein
was purified to 95% homogeneity with a yield of 45%. For the S.
albus G mutant, the culture and purification yields were 20
mg/liter and 25%, respectively; as stated above, the final prep-
aration was only 50% pure. Attempts to eliminate the low
molecular mass contaminant by various chromatographic pro-
cedures, including molecular sieve filtration, remained
unsuccessful.
Kinetic Properties—The values of the rate constants obtained
for the TEM-1 E166N mutant are reported in Table I. As
expected and in agreement with the observations of Adachi et
al. (11) and Strynadka et al. (9), the rates of deacylation (k3)
were exceedingly low.
Different strategies were utilized to determine the second-
order rate constant (k2/K￿), characteristic of the acylation rate.
Rapid acylation could not be monitored by the usual methods.
With [14C]benzylpenicillin, the reaction was so rapid that it
could not be followed by manual mixing methods. In conse-
quence, the first experiments were performed with compounds
exhibiting lower acylation rates and whose modifications upon
acyl-enzyme formation could be directly monitored by spectro-
photometric methods. The manual method A allowed the de-
termination of the k2/K￿ values for cephalosporin C, cefoxitin,
cefotaxime, and ceftazidime. That Equation 2 applied was con-
firmed by the fact that similar k2/K￿ values were obtained at
cefoxitin concentrations ranging from 20 to 40 ￿M. The stopped-
flow method, which required much larger quantities of proteins
TABLE I
Acylation rate constants (k2/K￿) and deacylation rate constants (k3) of the TEM-1 E166N mutant and wild-type enzymes with various ￿-lactams
For the WT enzyme, the k2/K￿ are the kcat/Km values and kcat supplies a minimum k3 value when it has not been independently measured. The
method used for determining the k2/K￿ values of the mutant protein is indicated between parentheses. The kinetic parameters for the WT enzyme
are from Raquet et al. (37), Fisher et al. (48), Christensen et al. (49), and Raquet (50).
Compound k2/K￿ WT k2/K￿ E166N Mutant/WT k3 WT k3 E166N
M￿1 s￿1 s￿1
Benzylpenicillin 84 ￿ 106 450 ￿ 103(C) 0.005 1500 5.2 ￿ 10￿6
Cephalosporin C 90 ￿ 103 2 ￿ 103(A￿C) 0.022 ￿36 0.71 ￿ 10￿6
Cephaloridine 2.24 ￿ 106 15 ￿ 103(C) 0.007 ￿1500 0.76 ￿ 10￿6
Cefoxitin 6 4.5 ￿ 103(A￿C) 750 4 ￿ 10￿3 —a
Moxalactam 16 3.5 ￿ 103(A) 219 —a —a
Temocillin *b 500(C) ￿150 —a —a
Cefotaxime 1.5 ￿ 103 2.5 ￿ 103(A) 1.7 ￿9 0.91 ￿ 10￿6
Cefuroxime 6 ￿ 103 6 ￿ 103(C) 1 ￿6 0.63 ￿ 10￿6
Ceftazidime 70 400(A) 5.7 ￿0.34 2.1 ￿ 10￿6
Imipenem 2 ￿ 103 30 ￿ 103 (C) 15 ￿2 ￿ 10￿2 —a
a Not determinated.
b No hydrolysis detected (3).
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was only utilized with cefoxitin. Here the antibiotic concentra-
tions were as high as 400 ￿M. An average k2/K￿ value of 2200 ￿
440 M￿1 s￿1 was found, in fair agreement with that obtained in
the manual mixing experiments (4500 ￿ 130 M￿1 s￿1). The
values for the other compounds were obtained by the competi-
tion method C. First, competitions between [14C]benzylpenicil-
lin and cephalosporin C or cefoxitin were performed, allowing
the computation of the k2/K￿ value for the
14C-labeled com-
pound. Subsequently, the values for all the other ￿-lactams
were derived from competition experiments with
[14C]benzylpenicillin.
For good substrates of the wild-type enzyme (benzylpenicil-
lin and cephaloridine), the E166N mutation resulted in a de-
crease of the acylation rates by 2–3 orders of magnitude. This
was, however, much less drastic than for the k3 value. The most
striking results concerned the modification of the substrate
profile.
In contrast to what occurred with the good substrates, the
k2/K￿ for the poorest WT substrates (i.e. temocillin, cefoxitin,
and moxalactam which bear a methoxy side chain on the ￿-face
of the ￿-lactam ring) were increased by several orders of mag-
nitude. With the oxyiminocephems, the k2/K￿ value was not
much affected. In consequence the k2/K￿ values of the mutant
only spanned 3 (from 400 to 400 ￿ 103) versus 7 orders of
magnitude for the wild-type protein.
With benzylpenicillin and the S. albus G E166H mutant,
similar results were obtained, involving a significant decrease
of k2/K￿ accompanied by a much more drastic decrease of k3
(Table II).
Effect of the pH on Catalytic Parameters—The pH depend-
ence of the acylation rate of the E166N mutant by cefoxitin was
studied using method A (see Fig. 1). The pH dependence of the
k2/K￿ value could be fitted to Equation 6 with pK1 and pK2
values of 6.0 and 8.5, respectively. With the wild-type enzyme
pK values of 7.2 and 9 were found. The mutation thus resulted
in a shift of the curve to lower pH values, with a more signifi-
cant effect to the acid limb. The k3 constant was not signifi-
cantly influenced by the pH value (not shown).
The k2/K￿ value of the E166H mutant of the S. albus G
￿-lactamase (Table II) exhibited a new pH dependence which
seemed to indicate that the base form of the His-166 side chain
was adequately oriented to actively participate in the acylation
step. By contrast, the k3 value at pH 5 was higher than at pH
7 or 9. This suggested that the His-166 residue of the mutant
enzyme was not involved in the deacylation step as a general
base catalyst.
Stability of the E166N TEM-1 Mutant—The melting temper-
ature (Tm) and the enthalpy (￿Hm) of unfolding obtained by
fitting the experimental curves to Equation 7 were: 51.1 ￿
0.2 °C and 112 ￿ 7 kcal/mol °C, 43 ￿ 1.4 °C and 87 ￿ 5 kcal/
mol °C for the wild-type and the E166N mutant proteins, re-
spectively. This result highlighted a significant destabilization
of the mutant which was corroborated by the proteolysis exper-
iments in which the pseudo-first order rate constants (ki) char-
acterizing trypsin-mediated inactivation were 0.29 min￿1 and
0.012 min￿1 for the TEM-1 E166N and WT proteins (33),
respectively.
Models of the Mutant Enzymes—The strong hydrogen bonds
found between the carboxylic group of Glu-166 and the side
chain nitrogen atoms of Lys-73 and Asn-170 of TEM-1 disap-
peared in the E166N mutant, allowing free rotation of these
residues. In the most stable structure obtained by conforma-
tional analysis, the Asn-170 acyl group was rotated by 180°
around the C￿-C￿ bond with respect to the orientation found in
the WT enzyme. A similar rotation was observed in the struc-
ture of the E166A mutant of the B. licheniformis ￿-lactamase
(34). There was no change in the position of Lys-73 relative to
its WT position. All calculations were performed considering
both the protonated and unprotonated states of Lys-73 and
yielded similar results.
The position of the “catalytic” water molecule in the mutant
was found to be the same whether it was generated by a Monte
Carlo simulation or minimized from the position found in the
WT structure. The water hydrogen atoms were oriented toward
the Asn-166 and Asn-170 O￿s, respectively. By comparison with
the WT structure, it was shifted by 1.3 Å away from Ser-70
with which it no longer formed a H-bond (Fig. 2).
In the E166H mutant, the plane of the imidazole side chain
was rotated by 75° with respect to that formed by the gluta-
mate carboxylate in the WT enzyme. The catalytic water mol-
ecule slightly (0.8 Å) moved to the bottom of the cavity away
from its initial position and was thus further from Ser-70. The
lengths of the hydrogen bonds were 3.12 and 2.85 Å with an
unprotonated and protonated Lys-73 residue, respectively, as
previously shown in the model of the E166D mutant of the S.
albus G enzyme (35). The N170 side chain was more outward-
oriented due to a 30° rotation around the C￿-C￿ bond.
Modeled Interactions of the E166N Mutant with ￿-Lactam
Substrates—Three cephalosporins: cephaloridine, cefuroxime,
and cefoxitin, respectively, good, bad, and very bad substrates
of the WT TEM-1 but of similar properties with the mutant
were chosen as models for the study of the specificity of the
E166N mutant. Benzylpenicillin was also studied (not shown),
TABLE II
Acylation (k2/K￿) and deacylation rate constants (k3) of the S. albus G
￿-lactamase E166H mutant and of the wild-type enzyme with
benzylpenicillin
The k2/K￿ values for the mutant were determined by direct binding of
a labeled antibiotic (method D). For the WT values see the footnote to
Table I.
pH E166H k2/K￿ WT kcat/Km E166H k3 WT k3
M1 s￿1 s￿1
5 6,000 1,950 ￿ 103 1.8 ￿ 10￿3 ￿3,800
7 10,000 3,000 ￿ 103 3.9 ￿ 10￿4 ￿3,400
9 32,000 2,300 ￿ 103 4.5 ￿ 10￿4 ￿2,800
FIG. 1. pH dependence of the second-order acylation rate con-
stant (k2/K￿) of the TEM-1 E166N and wild-type enzymes. ●, WT;
and E, E166N mutant. Above pH 10.5, spontaneous hydrolysis of the
antibiotic did not allow precise measurements. S.D. values were below
20%. The solid line was obtained by fitting data to Equation 6. Fitting
with klim2 ￿ 0 lead a somewhat poorer fit in the low pH range. It was,
however, not possible to be certain that this was statistically
meaningful.
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yielding results similar to those obtained with cephaloridine
(Fig. 3A).
The optimized structures of the Michaelis complexes were
not very different from those found in the case of the WT
enzyme. In all the complexes, the catalytic water molecule
remained positioned as in the free mutant (Fig. 3B), so that it
was not perturbed by the C7-methoxy group of cefoxitin, a
situation very different from that observed with the WT en-
zyme. With cefuroxime the main additional observation was a
decrease of the steric hindrance between the oxyimino group
and the N170 side chain (Fig. 3C). Deprotonation of Lys-73 only
resulted in a slight increase of the distance between the water
and the Ser-70.
Interaction of the E166H Mutant with Benzylpenicillin—The
optimized Henri-Michaelis complex was not very different from
that computed for the wild-type enzyme (Fig. 4). The major
difference was that the NH-CO bond of the C-6 substituent of
penicillin was now closer to the N170 side chain due to the
displacement of the latter (about 3 Å).
DISCUSSION
Both mutant proteins were more poorly produced than the
WT enzymes. This might be related to the relative instability of
the mutant proteins which increases their sensitivity to pro-
teases as shown for the TEM-1 E166N mutant. With this pro-
tein, utilization of a minimal medium and a lower temperature
significantly improved the production yield. This instability
might due to an increased mobility of the ￿-loop as shown for
various other TEM-1 mutants (36, 37).
On the basis of a preliminary study of the TEM-1 E166N
mutant, Adachi et al. (11) concluded that the deacylation rate
was severely decreased while the acylation reaction was unim-
paired. Since the first conclusion was in disagreement with the
data of Gibson et al. (13) and Leung et al. (38), however,
obtained with different Glu-166 mutants of another enzyme, a
careful kinetic study of the TEM-1 E166N protein was per-
formed. As expected and with all substrates, our results indi-
cated extremely large decreases of the k3 value, a 10
9 factor for
benzylpenicillin. This result underlined the pivotal role of the
Glu-166 in the deacylation step, a feature on which a general
consensus has been reached. By contrast, with the good sub-
strates, the k2/K￿ value, which characterizes the efficiency of
acylation and corresponds to the kcat/Km of the WT enzyme,
was decreased by 2 or 3 orders of magnitude indicating a
non-negligible, although less pivotal role of Glu-166 in the
acylation step. This was, however, not true for all substrates
since the acylation rates by poorer substrates were unchanged
or even slightly increased and for the very bad substrates,
cefoxitin and other compounds exhibiting a methoxy group on
the ￿-face, acylation was significantly facilitated.
Consequently, the “activity” profile of the enzyme was deeply
modified, with a spectacular leveling effect. According to
Strynadka et al. (9), the position of the ￿-loop was not strongly
modified in the mutant. The situation was the same with the B.
licheniformis E166A mutant but quite different with the
TEM-1 E166Y (39) and S. aureus D179N (40) proteins where
the loop was disordered. Here the most striking structural
modifications were the displacement of the water molecule W1
away from the active site Ser-70 side chain and the disappear-
ance of several strong hydrogen bonds. It should be noted that
this water molecule has been hypothesized to serve as a relay
in the activation of the Ser-70 hydroxyl group by the Glu-166
side chain acting as a general base in the acylation process.
However, an alternative mechanism has been proposed by
Strydnaka et al. (9), where the general base would be the
unprotonated side chain of Lys-73 and the Glu-166 carboxylate
in the acylation and deacylation steps, respectively. Although it
would explain the properties of E166X mutants which would
catalyze the acylation reaction with the same efficiency as the
wild-type enzyme but would fail to deacylate, this hypothesis
also implies a significantly decreased pKa value for the alky-
lammonium group of the lysine 73 side chain in the wild-type
enzyme. A recent NMR titration of the Lys-73 residue in the
TEM-1 protein failed to supply evidence for such unusual pKa
value (41). Other Glu-166 mutants have been prepared with
other enzymes (12, 38, 42). Whenever detailed kinetic studies
were performed, both acylation and deacylation rates appeared
to be decreased by the mutation, although deacylation was
sometimes much more severely impaired. Moreover, the K73R
mutant of the B. cereus 569/H ￿-lactamase I (13) was signifi-
cantly more active than its E166D counterpart. The drastic
substrate profile modifications observed in this present study
suggest that the acylation of the mutant might rely on an
alternative mechanism. One can hypothesize that, as proposed
by Lamotte-Brasseur et al. (10) and Matagne et al. (43), the
very low acylation rates of the WT enzyme by cefoxitin, moxa-
lactam, and temocillin are due to a displacement of W1 by the
methoxy side chain of the substrates. With the mutant, the
Lys-73 side chain might replace Glu-166 as the general base as
in acetoacetate decarboxylase (44) and as suggested by
Strynadka et al. (9) for the WT ￿-lactamase. The disappearance
of the negative Glu-166 charge would explain a decrease of the
Lys-73 pKa when compared to the WT enzyme.
This alternative acylation mechanism would be significantly
less efficient for good substrates but, since it would not involve
W1, the reaction rates with cefoxitin and similar compounds
would be increased. Finally, the unchanged acylation rates
with oxyiminocephalosporins would result from the same neg-
ative factor as with the good substrates compensated by a
positive effect due to the increased mobility of the omega loop
as observed for example with the Arg-164 mutants of the
TEM-1 enzyme (37).
Note that an unprotonated Lys-73 may not be necessary to
act as a proton relay. The softness of the electronic atmosphere
of the nitrogen atom allows an easy adaptation to environmen-
FIG. 2. Active site of the TEM-1 ￿-lactamase E166Nmutant. The
position of the W1 water molecule in the wild-type enzyme is shown as
Q. The backbone atoms are represented as filled circles.
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tal modifications such as the binding of a ligand. It is finally
interesting to note that the acylation rates observed with the
E166N mutant are of the same order of magnitude as those
measured with several penicillin-binding proteins. The Actino-
madura R39 (45) DD-peptidase and B. licheniformis PBP1 (46)
contain all the residues constituting the conserved elements of
the class A ￿-lactamases with the exception of the ￿-loop and,
in consequence, have no equivalent of Glu-166 as shown by the
three-dimensional structures of the homologous Streptococcus
pneumoniae PBP2x (47) and Streptomyces K15 DD-peptidase.2
The results obtained with the S. albus G enzyme generally
support these conclusions. In this case, the k3 value is also
strongly decreased and this residue does not appear to act as a
general base in the deacylation reaction, as indicated by the
absence of significant variation of k3 between pH 5 and 9. By
contrast, the k2/K￿ value significantly increases with increasing
pH values and, although a real titration curve is not observed,
this might suggest that the base form of this residue might
participate in the acylation reaction.
These results underline a major role of the W1-Glu-166 pair
in the enzymatic acylation-deacylation process and indicate
that although Glu-166 is involved in both acylation and deacy-
lation reactions in class A ￿-lactamases, these two reactions
are not necessarily “mirror” images of each other since the2 E. Fonze´ and P. Charlier, personal communication.
FIG. 3.Modeling of the Michaelis complexes formed by the TEM-1 E166N ￿-lactamase with cephaloridine (A), cefuroxime (B), and
cefoxitin (C). The antibiotic molecules are represented by filled circles and black lines. The arrows indicate the oxyimino group and the C7
￿-methoxy groups of cefuroxime and cefoxitin, respectively.
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disappearance of Glu-166 affects the two steps in a different
way. A careful kinetic analysis of mutant enzymes is thus a
prerequisite to meaningful mechanistic conclusions.
Acknowledgment—We thank Dr. X. Raquet for many fruitful
discussions.
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FIG. 4. Modeling of the Michaelis complex formed by the
E166Hmutant of ￿-lactamase of S. albus G and benzylpenicillin.
The antibiotic molecule is represented by filled circles and black lines.
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